HOME › DRUGS › OLARATUMAB
ACTIVE SUBSTANCE / INN

OLARATUMAB

Brand name(s): LARTRUVO, Lartruvo
FDA LISTED
EMA LISTED
PRESCRIPTION
REVOKED
BLA761038
Sarcoma
ACTIVE SUBSTANCE
Olaratumab
REGULATORS
FDA · EMA
SPONSORS / MAH
Eli Lilly Nederland B.V., ELI LILLY AND CO
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
LARTRUVOBLA761038ELI LILLY AND COPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
LartruvoEli Lilly Nederland B.V.Revoked09/11/2016Sarcoma

FULL INTELLIGENCE ON OLARATUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →